Roche Holding AG (OTCMKTS:RHHBY) Given Average Rating of “Hold” by Analysts

Shares of Roche Holding AG (OTCMKTS:RHHBY) have received an average recommendation of “Hold” from the eleven research firms that are currently covering the stock, MarketBeat Ratings reports. Seven analysts have rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average 12 month price objective among brokers that have issued a report on the stock in the last year is $51.50.

A number of equities analysts have issued reports on the company. HSBC lowered Roche from a “buy” rating to a “hold” rating in a research note on Monday. Morgan Stanley raised Roche from an “underweight” rating to an “equal weight” rating and set a $46.00 target price for the company in a research note on Friday, April 24th. Finally, Argus raised Roche from a “hold” rating to a “buy” rating in a report on Monday, April 6th.

Roche Price Performance

Roche stock opened at $52.02 on Friday. Roche has a 12-month low of $37.51 and a 12-month high of $60.85. The company has a current ratio of 1.38, a quick ratio of 1.12 and a debt-to-equity ratio of 0.72. The firm has a 50 day simple moving average of $51.32 and a 200-day simple moving average of $52.73.

Hedge Funds Weigh In On Roche

Hedge funds have recently made changes to their positions in the business. Meritage Portfolio Management acquired a new stake in Roche during the fourth quarter valued at approximately $4,372,000. Hantz Financial Services Inc. grew its position in Roche by 164.9% in the fourth quarter. Hantz Financial Services Inc. now owns 79,732 shares of the company’s stock worth $4,112,000 after buying an additional 49,633 shares during the last quarter. PNC Financial Services Group Inc. increased its holdings in shares of Roche by 5.4% in the first quarter. PNC Financial Services Group Inc. now owns 23,456 shares of the company’s stock valued at $1,166,000 after buying an additional 1,201 shares in the last quarter. McIlrath & Eck LLC acquired a new stake in shares of Roche during the 1st quarter valued at $39,000. Finally, Opal Capital LLC acquired a new stake in shares of Roche during the 1st quarter valued at $4,448,000.

About Roche

Roche Holding AG is a Swiss multinational healthcare company headquartered in Basel, founded in 1896 by Fritz Hoffmann‑La Roche. The company operates primarily through two complementary divisions — Pharmaceuticals and Diagnostics — and is known for integrating drug development with diagnostic capabilities to advance personalized healthcare. In the United States and other international markets, shares trade as American Depositary Receipts under the ticker RHHBY (OTCMKTS:RHHBY).

In pharmaceuticals, Roche focuses on developing and commercializing prescription medicines across therapeutic areas including oncology, immunology, infectious diseases and neuroscience, with a notable emphasis on targeted biologics and personalized therapies.